{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:40:07Z","timestamp":1790710807505,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21DZ2300300"],"award-info":[{"award-number":["21DZ2300300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e33735","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T15:10:16Z","timestamp":1719501016000},"page":"e33735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8171-9217","authenticated-orcid":false,"given":"Lixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e33735_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e33735_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33735_bib4","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12879-022-07543-8","article-title":"Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.99.1.169","article-title":"Endotoxemia in human septic shock","volume":"99","author":"Danner","year":"1991","journal-title":"Chest"},{"issue":"2 Suppl","key":"10.1016\/j.heliyon.2024.e33735_bib7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003246-199302001-00005","article-title":"Endotoxin-induced organ injury","volume":"21","author":"Ghosh","year":"1993","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33735_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","article-title":"Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome","volume":"119","author":"Casey","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/422254","article-title":"Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study","volume":"190","author":"Marshall","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1473-3099(10)70220-6","article-title":"Endotoxin removal devices for the treatment of sepsis and septic shock","volume":"11","author":"Davies","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1744-9987.1998.tb00066.x","article-title":"Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application","volume":"2","author":"Shoji","year":"1998","journal-title":"Ther. Apher."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","article-title":"Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)","volume":"7","author":"Shoji","year":"2003","journal-title":"Ther. Apher. Dial."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000046966","article-title":"Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis","volume":"19","author":"Nemoto","year":"2001","journal-title":"Blood Purif."},{"key":"10.1016\/j.heliyon.2024.e33735_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000315921","article-title":"Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature","volume":"167","author":"Cruz","year":"2010","journal-title":"Contrib. Nephrol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib15","first-page":"316","article-title":"[A meta-analysis of the effects of direct hemoperfusion with polymyxin B-immobilized fiber on prognosis in severe sepsis]","volume":"50","author":"Qiu","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33735_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0b013e31828cf412","article-title":"Blood purification and mortality in sepsis: a meta-analysis of randomized trials","volume":"41","author":"Zhou","year":"2013","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33735_bib17","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1097\/CCM.0000000000002362","article-title":"Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis","volume":"45","author":"Chang","year":"2017","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/sur.2016.168","article-title":"Hemoperfusion for sepsis and septic shock: a systematic review and meta-analysis","volume":"18","author":"Terayama","year":"2017","journal-title":"Surg. Infect."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33735_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.21037\/atm.2018.05.41","article-title":"Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials","volume":"6","author":"Kuriyama","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e33735_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcrc.2020.09.007","article-title":"Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: a systematic review and meta-analysis","volume":"63","author":"Li","year":"2021","journal-title":"J. Crit. Care"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33735_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33735_bib23","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00134-008-1124-6","article-title":"Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors","volume":"34","author":"Cantaluppi","year":"2008","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-020-00699-z","article-title":"Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial","volume":"10","author":"Chen","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.heliyon.2024.e33735_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcrc.2017.04.035","article-title":"Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients","volume":"43","author":"Lee","year":"2018","journal-title":"J. Crit. Care"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000725","article-title":"Modulation by polymyxin-B hemoperfusion of inflammatory response related to severe peritonitis","volume":"47","author":"Coudroy","year":"2017","journal-title":"Shock"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e33735_bib27","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e33735_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1744-9987.13655","article-title":"Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: analysis of a nationwide administrative database in Japan","volume":"25","author":"Fujimori","year":"2021","journal-title":"Ther. Apher. Dial."},{"issue":"4\u20135","key":"10.1016\/j.heliyon.2024.e33735_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000513213","article-title":"Effects of polymyxin B hemoperfusion on septic shock patients requiring noradrenaline: analysis of a nationwide administrative database in Japan","volume":"50","author":"Fujimori","year":"2021","journal-title":"BLOOD PURIFICAT"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13613-021-00928-z","article-title":"Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study","volume":"11","author":"Fujimori","year":"2021","journal-title":"Ann. Intensive Care"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33735_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4240\/wjgs.v11.i12.422","article-title":"Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock","volume":"11","author":"Kim","year":"2019","journal-title":"World J. Gastrointest. Surg."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33735_bib33","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","article-title":"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial","volume":"44","author":"Klein","year":"2018","journal-title":"INTENS CARE MED"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/SHK.0000000000001752","article-title":"Uncertain clinical effect of polymyxin B hemoperfusion in patients with septic acute kidney injury requiring continuous renal replacement therapy","volume":"56","author":"Lee","year":"2021","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000150","article-title":"Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis","volume":"42","author":"Iwagami","year":"2014","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000444474","article-title":"Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy: a propensity-matched analysis","volume":"42","author":"Iwagami","year":"2016","journal-title":"BLOOD PURIFICAT"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10388-014-0428-6","article-title":"Effectiveness of polymyxin B-direct hemoperfusion (PMX-DHP) therapy using a polymyxin B-immobilized fiber column in patients with post-esophagectomy sepsis","volume":"11","author":"Takahashi","year":"2014","journal-title":"ESOPHAGUS-TOKYO"},{"key":"10.1016\/j.heliyon.2024.e33735_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000315922","article-title":"EUPHAS Study Group: PMX endotoxin removal in the clinical practice: results from the EUPHAS trial","volume":"167","author":"Antonelli","year":"2010","journal-title":"Contrib. Nephrol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s000110050442","article-title":"Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and \u03b2-thromboglobulin","volume":"48","author":"Nakamura","year":"1999","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002480-200201000-00010","article-title":"Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis","volume":"48","author":"Nakamura","year":"2002","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00002480-200205000-00008","article-title":"Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma","volume":"48","author":"Nakamura","year":"2002","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/jhin.2002.1332","article-title":"Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus","volume":"53","author":"Nakamura","year":"2003","journal-title":"J. Hosp. Infect."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33735_bib43","doi-asserted-by":"crossref","first-page":"c33","DOI":"10.1159\/000071279","article-title":"Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis","volume":"94","author":"Nakamura","year":"2003","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.heliyon.2024.e33735_bib44","first-page":"417","volume":"23","author":"Nakamura","year":"2005","journal-title":"Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0b013e3181891131","article-title":"Urinary liver-type fatty acid-binding protein in septic SHOCK: effect of polymyxin B-immobilized fiber hemoperfusion","volume":"31","author":"Nakamura","year":"2009","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001533","article-title":"Identifying septic shock populations benefitting from polymyxin B hemoperfusion: a prospective cohort study incorporating a restricted cubic spline regression model","volume":"54","author":"Nakata","year":"2020","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13613-018-0465-8","article-title":"Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case\u2013control study","volume":"8","author":"Navas","year":"2018","journal-title":"Ann. Intensive Care"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173633","article-title":"Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33735_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"INTENS CARE MED"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33735_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000083","article-title":"Importance of endotoxin clearance in endotoxemic septic shock: an analysis from the evaluating use of PolymyxinB hemoperfusion in a randomized controlled trial of adults treated for endotoxemic septic shock (EUPHRATES) trial","volume":"2","author":"Rachoin","year":"2020","journal-title":"Critical care explorations"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13054-018-2077-y","article-title":"The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients","volume":"22","author":"Srisawat","year":"2018","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33735_bib52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1526-0968.2002.00416.x","article-title":"Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure","volume":"6","author":"Suzuki","year":"2002","journal-title":"Ther. Apher."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33735_bib53","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1525-1594.1998.06086.x","article-title":"Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column","volume":"22","author":"Tani","year":"1998","journal-title":"Artif. Organs"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","article-title":"A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection","volume":"23","author":"Vincent","year":"2005","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13054-017-1712-3","article-title":"Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study","volume":"21","author":"Nakamura","year":"2017","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33735_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5301\/ijao.5000549","article-title":"Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis","volume":"39","author":"Yuan","year":"2016","journal-title":"Int. J. Artif. Organs"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9610(94)90126-0","article-title":"Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber","volume":"167","author":"Aoki","year":"1994","journal-title":"Am. J. Surg."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33735_bib58","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1525-1594.1998.06086.x","article-title":"Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column","volume":"22","author":"Tani","year":"1998","journal-title":"Artif. Organs"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1744-9987.1998.tb00066.x","article-title":"Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application","volume":"2","author":"Shoji","year":"1998","journal-title":"Ther. Apher."},{"key":"10.1016\/j.heliyon.2024.e33735_bib60","first-page":"1429","volume":"161","author":"Bellomo","year":"2000","journal-title":"The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia"},{"key":"10.1016\/j.heliyon.2024.e33735_bib61","first-page":"3581","volume":"28","author":"Honore","year":"2000","journal-title":"Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock"},{"key":"10.1016\/j.heliyon.2024.e33735_bib62","first-page":"713","volume":"32","author":"Cornejo","year":"2006","journal-title":"High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock"},{"key":"10.1016\/j.heliyon.2024.e33735_bib63","volume":"359","author":"Palevsky","year":"2008","journal-title":"Intensity of renal support in critically ill patients with acute kidney injury"},{"key":"10.1016\/j.heliyon.2024.e33735_bib64","first-page":"803","volume":"37","author":"Payen","year":"2009","journal-title":"Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial"},{"key":"10.1016\/j.heliyon.2024.e33735_bib65","first-page":"1627","volume":"361","author":"Bellomo","year":"2009","journal-title":"Intensity of continuous renal-replacement therapy in critically ill patients"},{"key":"10.1016\/j.heliyon.2024.e33735_bib66","first-page":"1360","volume":"38","author":"Van Wert","year":"2010","journal-title":"High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis"},{"key":"10.1016\/j.heliyon.2024.e33735_bib67","first-page":"252","volume":"33","author":"Takeyama","year":"2012","journal-title":"Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients"},{"key":"10.1016\/j.heliyon.2024.e33735_bib68","first-page":"1017","volume":"74","author":"Doi","year":"2008","journal-title":"Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome"},{"key":"10.1016\/j.heliyon.2024.e33735_bib69","volume":"13","author":"Forin","year":"2023","journal-title":"Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33735_bib70","first-page":"130","article-title":"Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients","volume":"23","author":"Kawamata","year":"1997","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib71","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1399-6576.1998.tb05172.x","article-title":"Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection","volume":"42","author":"Iwama","year":"1998","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib72","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s002680020028","article-title":"Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients","volume":"25","author":"Tani","year":"2001","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33735_bib73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2003.12.067","article-title":"Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber","volume":"188","author":"Ono","year":"2004","journal-title":"Am. J. Surg."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-0968.2004.00167.x","article-title":"Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure","volume":"8","author":"Ikeda","year":"2004","journal-title":"Ther. Apher. Dial."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33735_bib75","doi-asserted-by":"crossref","first-page":"R653","DOI":"10.1186\/cc3815","article-title":"Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation","volume":"9","author":"Kushi","year":"2005","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e33735_bib76","volume":"8","author":"Payen","year":"2021","journal-title":"Endotoxin Mass Concentration in Plasma Is Associated With Mortality in a Multicentric Cohort of Peritonitis-Induced Shock"},{"key":"10.1016\/j.heliyon.2024.e33735_bib77","volume":"10","author":"Ueno","year":"2023","journal-title":"Cytokine modulation in abdominal septic shock via the crucial role of IL-6 signaling in endothelial dysfunction"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib78","first-page":"229","article-title":"Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock","volume":"10","author":"Tsujimoto","year":"2004","journal-title":"J. Endotoxin Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s000110050442","article-title":"Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin","volume":"48","author":"Nakamura","year":"1999","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s002680020028","article-title":"Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients","volume":"25","author":"Tani","year":"2001","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib81","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000046966","article-title":"Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis","volume":"19","author":"Nemoto","year":"2001","journal-title":"Blood Purif."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33735_bib82","first-page":"602","article-title":"Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis","volume":"32","author":"Nakamura","year":"2003","journal-title":"Dial. Transplant."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33735_bib83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-0968.2004.00167.x","article-title":"Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure","volume":"8","author":"Ikeda","year":"2004","journal-title":"Ther. Apher. Dial."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib84","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","article-title":"A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection","volume":"23","author":"Vincent","year":"2005","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33735_bib85","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/SHK.0b013e3181a2a978","article-title":"A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock","volume":"32","author":"Mitaka","year":"2009","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33735_bib86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jcrc.2010.11.010","article-title":"Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients","volume":"26","author":"Nakamura","year":"2011","journal-title":"J. Crit. Care"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33735_bib87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(00)01313-2","article-title":"Polymyxin B binds to anandamide and inhibits its cytotoxic effect","volume":"470","author":"Wang","year":"2000","journal-title":"FEBS LETT"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33735_bib88","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00134-004-2357-7","article-title":"Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis","volume":"30","author":"Nakamura","year":"2004","journal-title":"Intensive Care Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024097664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024097664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:55:17Z","timestamp":1778885717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024097664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":87,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024097664"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33735","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33735"}}